Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Nature Medicine

Volumn 8, Issue 1, 2002, Pages 68-74

  Shipp, Margaret A ^a   Ross, Ken N ^b   Tamayo, Pablo ^b   Weng, Andrew P ^c   Aguiar, Ricardo C T ^a   Gaasenbeek, Michelle ^b   Angelo, Michael ^b   Reich, Michael ^b   Pinkus, Geraldine S ^c   Ray, Tane S ^e   Koval, Margaret A ^a   Last, Kim W ^d   Norton, Andrew ^d   Lister, T Andrew ^d   Mesirov, Jill ^b   Neuberg, Donna S ^a   Lander, Eric S ^b,f   Aster, Jon C ^c   Golub, Todd R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF THE WEST INDIES   (Jamaica)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROTEIN SERINE THREONINE KINASE; VINCRISTINE;

ADULT; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MACHINE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTIFICIAL INTELLIGENCE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREDNISONE; TREATMENT OUTCOME; VINCRISTINE;

EID: 18244409933     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0102-68     Document Type: Article

References (45)

1. A clinical evaluation of the International Lymphoma Study Group classification of the non-Hodgkin's lymphoma
2. The non-Hodgkin's lymphomas
3. A predictive model for aggressive non-Hodgkin's lymphoma
4. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury
5. A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma
6. Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: Relationship with tumor dissemination and prognostic importance
7. Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
8. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
9. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
10. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
11. BAL is a novel risk-related gene in diffuse large B-cell lymphomas which enhances cellular migration
12. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
13. Cellular origin or human B-cell lymphomas
14. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
15. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma
16. HMG-I/Y, a new c-Myc target gene and potential oncogene
17. Signal transduction via CD44: Role of plasma membrane microdomains
18. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
19. Structural basis of BFL-1 for its interaction with BAX and its antiapoptotic action in mammalian and yeast cells
20. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
21. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
22. The prosurvival Bcl-2 homolog Bfl-1/Al is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis
23. The human PD-1 gene: Complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors
24. A death-domain-containing receptor that mediates apoptosis
25. Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas
26. A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection
27. The CD69 receptor: A multi-purpose cell-surface trigger for hematopoietic cells
28. V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene
29. Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes
30. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: Prognostic significance of E2F-1 and p16NK4A
31. Mitochondria - The death signal integrators
32. 2+-induced release of the transcription factor MEF2
33. Nur77 transcription activity correlates with its apoptotic function in vivo
34. Positive and negative thymic selection in T cell receptor-transgenic mice correlate with Nur77 mRNA expression
35. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
36. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B
37. The cAMP signaling pathway as a therapeutic target in lymphoid malignancies
38. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia
39. Expression of protein kinase C genes in hemopoietic cells is cell-type- and B cell-differentiation stage specific
40. Immunodeficiency in protein kinase Cb-deficient mice
41. Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells
42. Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy
43. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
44. Cluster analysis and display of genome-wide expression patterns